Şahin Çelik, B.; Peker, P.; Özçelik, E.E.; Kuzu, Ö.F.; Gökmen, E.; Başaran, G.; Evrensel, T.
Real-World Outcomes of Adjuvant Paclitaxel and Trastuzumab Therapy in Lymph Node-Negative, HER2-Positive Early-Stage Breast Cancer: A Multicenter Retrospective Data Analysis. Cancers 2025, 17, 2271.
https://doi.org/10.3390/cancers17142271
AMA Style
Şahin Çelik B, Peker P, Özçelik EE, Kuzu ÖF, Gökmen E, Başaran G, Evrensel T.
Real-World Outcomes of Adjuvant Paclitaxel and Trastuzumab Therapy in Lymph Node-Negative, HER2-Positive Early-Stage Breast Cancer: A Multicenter Retrospective Data Analysis. Cancers. 2025; 17(14):2271.
https://doi.org/10.3390/cancers17142271
Chicago/Turabian Style
Şahin Çelik, Buket, Pınar Peker, Ender Eren Özçelik, Ömer Faruk Kuzu, Erhan Gökmen, Gül Başaran, and Türkkan Evrensel.
2025. "Real-World Outcomes of Adjuvant Paclitaxel and Trastuzumab Therapy in Lymph Node-Negative, HER2-Positive Early-Stage Breast Cancer: A Multicenter Retrospective Data Analysis" Cancers 17, no. 14: 2271.
https://doi.org/10.3390/cancers17142271
APA Style
Şahin Çelik, B., Peker, P., Özçelik, E. E., Kuzu, Ö. F., Gökmen, E., Başaran, G., & Evrensel, T.
(2025). Real-World Outcomes of Adjuvant Paclitaxel and Trastuzumab Therapy in Lymph Node-Negative, HER2-Positive Early-Stage Breast Cancer: A Multicenter Retrospective Data Analysis. Cancers, 17(14), 2271.
https://doi.org/10.3390/cancers17142271
